Skip to main content

Advertisement

Figure 2 | Malaria Journal

Figure 2

From: The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea

Figure 2

Maximum likelihood estimates of mutant allele frequencies at the two study sites. Error bars denote 95% confidence intervals; * denotes statistical significance at the 95% level; CQ, chloroquine; SP, sulphadoxine-pyrimethamine; pfmdr1, Plasmodium falciparum multidrug resistance gene 1; pfcrt, Plasmodium falciparum chloroquine resistance transporter; pfdhfr, Plasmodium falciparum dihydrofolate reductase; pfdhps, Plasmodium falciparum dihydropteroate synthase.

Back to article page